Determination of Belotecan in the Plasma,Bile, and Urine of Rats by High-Performance Liquid Chromatography with Fluorescence Detection and Its Application to a Pharmacokinetic Study

Abstract

A simple and reliable high-performance liquid chromatographic (HPLC) method was developed for the determination of belotecan in the plasma, urine, and bile samples of rats. Belotecan was analyzed with HPLC using a C18 column with fluorescence detector. A mixture of acetonitrile–0.1 M potassium phosphate buffer at pH 2.4 (25:75, v/v) and 0.2% trifluoroacetic acid was used as the mobile phase. The lower limits of quantitation (LOQ) were 5 ng mL^?1 for the plasma and 5 µg mL^?1 for the urine and bile samples. The method has been readily applied for the routine pharmacokinetic study of belotecan in small laboratory animals.     

Determination of Steroids in Human Urine by Micellar Liquid Chromatography

Abstract

A simple and sensitive method for the determination of steroids using micellar liquid chromatography is described. The steroids, including hydroxycorticosterone. corticosterone, northisterone, testosterone, mexdroprogesterone acetate and progesterone, were separated by reversed-phase using a micelles mobile phase following UV detection at 245 nm. The parameters affecting retention of the test solutes such as the concentration of sodium dodecyl sulfate (SDS) and n-butanol-1 in the mobile phase were investigated. It was found that the retention of the solutes was dependent on the composition of mobile phase. The linear calibration plots range from 0.1 to 10 μg ml^?1 in mobile phase containing 5.0 × 10^?2 mol l^?1 SDS/9 % n-butanol-1 at pH 6.0, and the detection limit in order of 0.1 μg ml^?1 was obtained. The proposed method was used for the determination of steroids in urine using direct injection of samples without previous treatment.     

Octadecyl Bonded Silica Membrane Disk Modified with Cyanex302 for Preconcentration and Determination of Traces of Cobalt in Urine by Flame Atomic Absorption Spectrometry

Abstract

Octadecyl bonded silica membrane disk was impregnated with Cyanex302 for flame atomic absorption spectrometric determination of traces of cobalt(II) in urine. The solid phase extraction method developed using the modified disk was systematically investigated for sorption-desorption of cobalt(II). Cobalt(II) was quantitatively sorbed on the disk at pH 6.0 and eluted using 15 cm³ of 1 × 10^?3 M HCl. The lower limit of detection for cobalt(II) was 1.5 µg dm^?3 and the preconcentration factor 133 with a precision in terms of relative standard deviation (% R. S. D.) 0.6. The reusability of the modified disk was ≥35 cycles.     

Colorimetric Determination of Ampicillin and 6-Aminopenicillanic Acid Using Acenaphthenequinone as a Chromophoric Reagent

Abstract

A colorimetric method for the determination of ampicillin (Amp.) and 6-aminopenicillanic acid (6-APA) are described, based on the reaction of these drugs with acenaphthenequinone in basic media to give a highly intense red coloured product. The latter exhibits an absorption maximum at 610 nm with apparent molar absorptivities of 2.83 and 1.45 × 10⁴ l. mol^?1 cm^?1 and Sandell sensitivities of 0.013 and 0.015 μg cm^?2 for Amp. and 6-APA, respectively. The optimum concentration ranges are 0.4-10 and 0.4-14 μg ml^?1 for Amp. and 6-APA, respectively. For more accurate results, Ringbom optimum concentration ranges are 1–8.5 and 1–12 μg ml^?1 for Amp. and 6-APA, respectively. Statistical analysis indicated that there was no significant difference between the results obtained by the described method and those of the official methods. The mean recoveries percentage were found to be 99.5 × 1.1% for pharmaceutical formulations and 99.1 × 1.6% for serum and urine samples. The method is selective for the determination of Amp. or 6-APA in the presence of their degradation products, additives and excipiences that are normally encountered in dosage forms. The proposed method was applied successfully to the determination of Amp. in pharmaceutical formulations. Also, applicability of the proposed method to human serum and urine is presented and the validity assessed by applying the standard addition technique.     

Optimization and Validation of an LC Method for the Determination of Cefdinir in Dosage Form and Human Urine

A simple and reliable liquid chromatographic method has been developed and validated for the determination of cefdinir in human urine and capsule samples. A chromatographic separation was achieved on a C₁₈ column using a mobile phase consisting of potassium dihydrogen phosphate (10 mM, pH 4.5)–acetonitrile (90:10, v/v). Quantitation was achieved with UV detection at 285 nm, based on peak area with linear calibration curve at a concentration range of 0.7–39 µg mL⁻¹. This method was successfully applied for the establishment of an urinary excretion pattern after oral dose.

     

Simultaneous Determination of Toxic Alkaloids in Blood and Urine by HPLC–ESI–MS/MS

A sensitive and selective method for simultaneous determination of 29 toxic alkaloids in human blood and 31 in urine using high-performance liquid chromatography–electrospray ionization-tandem mass spectrometry was developed and validated. The samples were diluted with 0.1 mol L⁻¹ HCl, and the target alkaloids were purified by solid phase extraction. The separation of 31 alkaloids was carried out on a C18 column using a gradient mobile phase with 10 mmol L⁻¹ ammonium formate in water with 0.1% formic acid and methanol at the rate of 0.25 mL min⁻¹. The triple-quadrupole mass spectrometer equipped with an electrospray source in the positive mode was set up in the dynamic multiple reactions monitoring mode (dynamic MRM) to detect the ion transitions of 31 alkaloids. The calibration curves were linear over a range of 0.5–400, 1–400, or 4–400 μg L⁻¹ for target alkaloids in human blood and urine, and the correlation coefficients (r ²) was higher than 0.9943. The limit of determination and limit of quantification were 0.2–1 and 0.5–4 μg L⁻¹ for blood and urine, respectively. The only exceptions were sanguinarine and chelerythrine in human blood. All the target alkaloids were stable under the test condition. In addition, the solvent effect and reconstituted solution were investigated. The method was validated and proved to be accurate and precise over the studied concentrations and suitable for poisoning diagnosis and forensic toxicology.

     

Chromatographic Tandem Mass Spectrometric Detection of Physostigmine and its Major Metabolites in Rat Urine

Abstract

A rapid, sensitive, and specific liquid chromatographic‐electrospray ionization (ESI) tandem ion trap mass spectrometric method has been developed for identification of physostigmine and its metabolites in rat urine. 300 µg kg^–1 of physostigmine were used as a safe oral gavage dose for studies on its metabolites. 0–24 h urine was purified using a C18 solid‐phase extraction cartridge, and then detected by an on‐line MS detector. Identification and structural elucidation of the metabolites were performed by comparing their MSⁿ spectra with physostigmine. Six metabolites and unchanged physostigmine existed in rat urine. All of the metabolites were reported for the first time.     

Kinetic Spectrophotometric Determination of Nanogram Levels of Manganese (II) Based on its Catalytic Effect on the Oxidation of an Azo Compound with Potassium Periodate in the Presence of 1, 10-Phenanthroline

ABSTRACT

The catalytic effect of manganese (II) on the oxidation of Diphenylamine-4-azo-benzen-4'-sulfonic acid potassium salt with potassium periodate in the presence of 1, 10-phenanthroline in weakly acidic media was studied. A catalytic kinetic spectrophotometric method for determination of manganese (II) in the range 0.05 – 2.5 ng ml-^?1 can be determined by the fixed-time method with a detection limit of 0.017 ng ml-^?1. The method was applied successfully to the determination of manganese (II) in tap water and human urine.     

Stereoselective Determination of Ornidazole Enantiomers in Human Plasma and Urine Samples by Chiral LC: Application to Pharmacokinetic Study

A stereoselective liquid chromatographic method to determine the enantiomers of ornidazole in human plasma and urine has been developed and validated. After addition of the internal standard (naproxen), samples were acidified and extracted with diethyl ether. The separation was performed on a Chiralcel OB-H column, using hexane-ethanol- glacial acetic acid (94:6:0.08, v/v) as the mobile phase. The method was validated for specificity, linearity, sensitivity, precision, accuracy and stability. For each enantiomer of ornidazole, linear calibration curves were obtained over the concentration range of 0.16–20 μg mL⁻¹ in plasma and 0.32–20 μg mL⁻¹ in urine. For both enantiomers of ornidazole in plasma and urine, the coefficient of variation for precision were consistently less than 12% and accuracy were within ±14% in terms of relative error. Application of the method to a preliminary pharmacokinetic study showed that this validated method was qualified for the direct determination of ornidazole enantiomers in human plasma and urine.

     

Differential Pulse Polarographic Determination of Moxifloxacin Hydrochloride in Pharmaceuticals and Biological Fluids

Abstract

A simple, fast, sensitive and fully validated differential pulse polarographic (DPP) method for the determination of trace amounts of moxifloxacin in pharmaceutics, serum and urine is reported. Moxifloxacin exhibited irreversible cathodic peak over the pH 5.00–11.00 in Britton–Robinson (B–R) buffer. At pH 10.00 (the analytical pH), a well‐defined peak at ?1.61 V versus saturated calomel electrode was obtained. The current has been characterized as being diffusion‐controlled process. The diffusion current constant (i_d) was 1.48±0.12 and the current–concentration plot was rectilinear over the range from 5×10^?7 to 1×10^?4 M with correlation coefficient (n=10) of 0.995.

The proposed method was applied to commercial tablets and average percentage recovery was in agreement with that obtained by spectrophotometric comparison method. The method was extended to the in vitro determination of moxifloxacin in spiked human serum and urine.     

Rapid Determination of Pentazocine in Human Plasma and Urine by a Potentiometric Method

Abstract

A fast potentiometric determination method has been reported for pentazocine in human plasma without complicated pretreatments using a coated-wire potentiometric selective electrode. The sensing membrane was made by incorporating of ion-association complexes of pentazocine cation and sodium tetraphenyl borate (NaTPB) in a polyvinyl chloride. The sensor exhibited fast, stable, and linear Nernstian response over the range of 5 × 10^?5 to 0.1 mol L^?1 pentazocine with a slope of 57.8 mV per decade and with detection limit of 3.2 × 10^?5 mol L^?1. The proposed sensor has been used for determination of pentazocine in human plasma and urine.     

Determination of Pyridostigmine in Human Plasma by High-Performance Liquid Chromatography

Abstract

An easy to perform, specific, reproducible and sensitive high performance liquid chromatographic (HPLC) method to measure pyridostigmine concentration in human plasma was developed and validated. Sample clean-up consists of ion-pair extraction into dichloromethane in the presence of neostigmine as internal standard, followed by back extraction into an aqueous phase. Mean recovery of 110% (with a standard deviation of 10%) was determined for concentrations of 5 – 100 ng/ml. Chromatography on a 125·4 mm CN-propyl column using a mobile phase composed of 10% acetonitrile in 3.5×10^?4M NaH₂PO₄ and UV detection at 270 nm, yields clean chromatograms without any interferences from endogenous plasma components. Using 1 ml plasma samples the method has a limit of detection (LD) of 3 ng/ml, with %CV (precision) and bias (accuracy) ≥ 10% for concentrations in the range of 0–100 ng/ml. The method is being used in human pharmacokinetic studies of oral dosage forms of pyridostigmine.     

Flow-Injection Determination of Glucose by a Photoinduced Chemiluminescent Reaction

Abstract

A flow-injection procedure for the photochemical determination of glucose has been developed. The method is based on the photo-oxidation of glucose sensitized by 9,10-anthraquinone-2.6-disulfonate (disodium salt). The hydrogen peroxide formed in the photochemical reaction was measured by means of the chemiluminescent reaction with luminol and hematin. A linear calibration graph was obtained over the range 2.0x10^?6-8.5 x 10^?5 mol L^?1. The method was applied to determining glucose in blood serum, urine and fruit juices.     

Determination of Suramin in Plasma and Urine by Ion-Paired Reverse-Phase High-Performance Liquid Chromatography

Abstract

A high-pressure liquid chromatographic (HPLC) assay has been developed for the quantification of the anti-viral drug suramin (SUR) in human plasma and urine. This assay is simple and accurate, using an isocratic mobile phase in a reverse-phase ion-pairing mode.

This assay was developed for the determination of high levels of suramin in the urine and plasma of patients being treated for the acquired immunodefficiency Syndrome (AIDS). The limit of detection of this assay was 0.25 μg/mL. Congo red (CR) was used as the internal standard with a retention time of 5.9 min, while suramin had a retention time of 13 min.     

LC Determination of Ketorolac in Human Plasma and Urine for Application to Pharmacokinetic Studies

A simple, specific and sensitive liquid chromatographic method has been developed for the assay of ketorolac in human plasma and urine. The clean-up of plasma and urine samples were carried out by protein precipitation procedure and liquid–liquid extraction, respectively. Separation was performed by a Waters sunfire C₁₈ reversed-phase column maintained at 35 °C. The mobile phase was a mixture of 0.02 M phosphate buffer (pH adjusted to 4.5 for plasma samples and to 3.5 for urine samples) and acetonitrile (70:30, v/v) at a flow rate of 1.0 mL min⁻¹. The UV detector was set at 315 nm. Nevirapine was used as an internal standard in the assay of urine sample. The method was validated over the concentration range of 0.05–8 and 0.1–10 μg mL⁻¹ for ketorolac in human plasma and urine, respectively. The limits of detection were 0.02 and 0.04 μg mL⁻¹ for plasma and urine estimation at a signal-to-noise ratio of 3. The limits of quantification were 0.05 and 0.1 μg mL⁻¹ for plasma and urine, respectively. The extraction recoveries were found to be 99.3 ± 4.2 and 80.3 ± 3.7% for plasma and urine, respectively. The intra-day and inter-day standard deviations were less than 0.5. The method indicated good performance in terms of specificity, linearity, detection and quantification limits, precision and accuracy. This assay demonstrated to be applicable for clinical pharmacokinetic studies.

     

Studies on Steroids. CLXXXIL. Determination of 6β-Hydroxycortisol in Urine by High-Performance Liquid Chromatography with Fluorescence Detection

Abstract

A new sensitive method for the determination of 6β-hydroxycortisol in urine by high-performance liquid chromatography with fluorescence detection has been developed. 6β-Hydroxycortisol and its C-6 epimer (internal standard) were transformed quantitatively into the 21-(9-anthroyl) derivatives when treated with 9-anthroyl nitrile in the presence of triethylamine in acetonitrile. The resulting fluorescent esters were readily separated on a Cosmosil SSL column using ethyl acetate/hexane (2:1) as a mobile phase with a detection limit of 25 pg. The efficient clean-up was achieved by the combined use of Bond Elut and Clin Elut cartridges. The present method is applicable to the quantification of 6β-hydroxycortiol in human urine with satisfactory accuracy and precision.     

Separation and Quantitation of Urinary Phthalates by HPLC

Abstract

A method was developed for the separation and quantitation of plasticizers and their metabolites from human urine using HPLC, Urine was diluted with an equal volume of water and extracted at pH 2.0 with diethyl ether, The extract was dried, the solvent vacuum stripped, and the residue dissolved in methanol for injection into the chromatograph. A C₁₈ reverse phase column containing 10 μ particles was used for the analysis. Ionic suppression, 0.5% acetic acid in water, at pH 3.0 was used to resolve the acidic components. A step gradient of acetonitri1e:water (containing acetic acid) was used to elute the polar metabolites as well as the non-polar plasticizers. Mass spectrometry was used t o identify the compounds in the HPLC fractions. From the HPLC fractions of the urine extract collected, phthalic acid, MEHP, DEHP and normal urinary constituents (e.g., hippuric and benzoic acid derivatives) were identified     

Photochemical Fluorescence Enhancement of Terbuium-Fleroxacin System and Determination of Fleroxacin

ABSTRACT

The sensitized fluorescence of the terbium ion (Tb³⁺) can be observed when excited in the presence of fleroxacin (FLRX) in the aqueous solution because a Tb³⁺ -FLRX complex was formed. The sensitised fluorescence was greatly enhanced after the complex system was irradiated by 365nm ultraviolet light. The irradiation makes the complex system undergo photochemical reactions and a new terbium complex which is more favourable to the intramolecular energy transfer is formed. On this basis a new sensitive and selective photochemical fluorimetric method for the determination of FLRX was developed. Under the optimum experimental conditions, the linear range of the determination is 1.0—200×10^?7 mol 1^?1 for FLRX, and the detection limit is 1.2×10^?8mol 1^?1. Without any pre-treatment the recoveries of FLRX in human urine samples were determined with satisfaction.     

Size Exclusion Chromatographic Determination of PEG 3350 in Human Plasma and Urine

Abstract

A size exclusion chromatographic method is reported that quantitated PEG 3350 in human plasma and urine to a concentration of 10 μg/ml in plasma, or urine. The chromatographic system consisted of a 500 A gel permeation analytical column, a differential refractometer detector, and chloroform as the eluting solvent. Organic extraction was used as an initial separation technique. PEG 400 was used as the internal standard for PEG 3350, and showed similar extraction properties. Spiked plasma standards yielded standard calibration curves with correlation coefficients of greater than 0.99, and relative standard deviations (n=3) of 2.19% (500 μg/ml) and 6.97% (20 μg/ml). The analytical technique was used to estimate the elimination rate constant of PEG 3350 from 5 normal human subjects after oral administration of 240 grams of PEG 3350. K_E was found to be 0.1079 hr^?1 0.03781^?1 hr (mean s.d.) using the Sigma-minus data analysis method on total urines collected from the 5 subjects at varying intervals.     

Pyrocatechol-1-Aldehyde 2-Benzothiazolylhydrazone As Reagent for the Spectrofluorimetric Determination of Nanogram Amounts of Gallium in Urine and Blood Serum

Abstract

A method is developed for the spectrofluorimetric determination of 1–80 ng.ml^?1 of gallium with pyrocatechol-1-aldehyde 2-benzothiazolylhydrazone, in a 50% (v/v) DMSO-Water medium at apparent pH 4.0 (monochloracetic/monochloracetate buffer). Λ_ex = 400nm, Λ_em = 504 nm (corrected). Interferences have been evaluated and the method applied to the determination of gallium in human urine and blood serum samples.